iBio Stock (AMEX: IBIO) stock price, news, charts, stock research, profile.
Open | $1.90 |
Close | $1.97 |
Volume / Avg. | 66.46K / 287.46K |
Day Range | 1.90 - 2.03 |
52 Wk Range | 1.02 - 15.99 |
Market Cap | $16.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 40 |
Short Interest | 1.56% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of iBio (AMEX:IBIO) through any online brokerage.
Other companies in iBio’s space includes: Galecto (NASDAQ:GLTO), Monopar Therapeutics (NASDAQ:MNPR), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX) and Sensei Biotherapeutics (NASDAQ:SNSE).
There is no analysis for iBio.
iBio has a consensus price target of $1.72.
The stock price for iBio (AMEX: IBIO) is $2 last updated July 3, 2024 at 4:30 PM EDT.
There are no upcoming dividends for iBio.
iBio’s Q4 earnings are confirmed for Wednesday, September 25, 2024.
There is no upcoming split for iBio.
iBio is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.